As endocrine-disrupting chemicals, PFAS disrupt metabolic and hormonal homeostasis via pathways such as PPAR activation and can induce epigenetic alterations, leading to metabolic disorders, inflammation, and potential carcinogenic risks. The gene discussed is PPARA; the disease is Other metabolic disease.